# Multimodal Ventures

Multimodal Ventures is a Venture Capital based in Mountain View, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Mountain View, United States
- **Region:** North America
- **Address:** Mountain View, CA, United States
- **Assets under management:** Undisclosed
- **Website:** multimodalventures.com
- **LinkedIn:** https://www.linkedin.com/company/multimodal-ventures-studio

## Regulatory record

- **CRD number:** 334021
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/334021

## About

Multimodal Ventures is a venture capital fund that backs YC startups. Its mission is to consider every YC startup's unique opportunity across emerging founders and invest in what matters most, backing those it believes can lead and shape their industry while supporting growth. Its vision is to become a leading venture capital fund delivering significant returns to LPs through a diverse portfolio. It uses a proprietary AI algorithm called Midas to help determine investment decisions.

## Sectors

- AI/ML
- Enterprise Software

## Offices

- Burlingame, CA
- Naperville, IL
- Los Altos, CA

## People

- Jeff Heitzman — Founder and Managing Partner
- Niraj Shah — Co-founder and Managing Partner
- Ryan Havlick — Co-founder and Managing Partner
- Kelly Kozlowski — Director, Investor Relations
- Jean Ortega — Machine Learning, Software, and Data Engineering
- Tim McGee — Autonomous, Space, and Robotic Technology
- Andrew Bartynski — Bio Technology

## Questions

### Does the firm invest in therapeutic-asset companies or only in tool/platform builders?

The observable portfolio emphasizes platform and tool builders — companies creating the computational infrastructure that pharma and biotech customers use to discover or design their own assets. While the firm has not published an explicit exclusion of therapeutic-asset companies, its thesis favors companies whose primary product is software or software-enabled discovery capabilities rather than clinical-stage drug candidates.

### How does Multimodal Ventures differentiate itself from other AI-focused seed funds?

The firm's narrow focus on multimodal biology — rather than broad horizontal AI — sets it apart. Many seed funds allocate a portion of capital to healthcare AI as one of several sectors. Multimodal Ventures was built exclusively for that convergence, competing on domain expertise and network depth within the specific community of founders who straddle deep learning and life sciences.

## Related profiles

- [Scott Group](https://altss.com/profile/scott-group)
- [AccelByte](https://altss.com/profile/accelbyte-inc)

---

Last updated: 2026-08-11T15:07:34.613Z

Canonical page: https://altss.com/profile/multimodal-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology